It was an all-or-nothing kind of quarter for Wilbur Ross (Trades, Portfolio), but that is pretty much the way each quarter has been recently for Ross, founder of private equity firm WL Ross & Co. Sometimes he does reduce or add to existing stakes in his portfolio, but much of the time he buys or sells stakes, as he did in the second quarter.
The majority of Ross’ five second-quarter transactions were sales of stakes from his portfolio, but his most noteworthy deal was his purchase of a 269,282-share stake in InterXion Holding NV (INXN, Financial), an Amsterdam-based provider of carrier and Cloud-neutral co-location data center services. Ross paid an average price of $29.64 per share in an acquisition that had a 0.94% impact on his portfolio.
InterXion Holding has a market cap of $1.92 billion and an enterprise value of $2.46 billion. It has a P/E of 38.7, a Price/Book of 3.5 and a Price/Sales of 4.5. John Paulson (Trades, Portfolio), David Abrams (Trades, Portfolio), Jeremy Grantham (Trades, Portfolio), Jim Simons (Trades, Portfolio), Manning & Napier Advisors Inc., Mario Cibelli (Trades, Portfolio), Chris Davis (Trades, Portfolio) and Mario Gabelli (Trades, Portfolio) have shares of InterXion Holding in their portfolios.
Ross also bought a 30,014-share stake in Intersect ENT Inc. (XENT, Financial), a Menlo Park, Calif.-based health care equipment company. Ross paid an average price of $26.2 per share. The deal had a 0.11% impact on Ross’ portfolio.
Intersect ENT has a market cap of $729.99 million and an enterprise value of $593.5 million. It has a Price/Book of 4.4 and a Price/Sales of 11.6. RS Investment Management (Trades, Portfolio), Chuck Royce (Trades, Portfolio), Steven Cohen (Trades, Portfolio), Jim Simons (Trades, Portfolio), Ron Baron (Trades, Portfolio) and Paul Tudor Jones (Trades, Portfolio) have shares of Intersect ENT in their portfolios.
Ross sold three stakes in the second quarter – Inphi Corp. (IPHI, Financial), T2 Biosystems Inc. (TTOO, Financial) and Nimble Storage Inc. (NMBL, Financial).
Ross sold his 61,424-share stake in Inphi Corp., a Sunnyvale, Calif.-based high-speed analog semiconductor company, for an average price of $22.14 per share. That sale had a -0.14% impact on his portfolio.
Inphi has a market cap of $944.82 million and an enterprise value of $857.45 million. It has a Price/Book of 3.9 and a Price/Sales of 4.2. Chuck Royce (Trades, Portfolio), Jim Simons (Trades, Portfolio) and Paul Tudor Jones (Trades, Portfolio) have shares of Inphi in their portfolios.
Ross parted with his 35,000-share stake in T2 Biosystems, a Lexington, Mass.-based molecular diagnostics firm, for an average price of $17.32 per share. The divestiture had a -0.07% impact on Ross’ portfolio.
T2 Biosystems has a market cap of $244.91 million and an enterprise value of $212.45 million. It has a Price/Book of 7.2 and a Price/Sales of 241. Steven Cohen (Trades, Portfolio) and Jim Simons (Trades, Portfolio) have shares of T2 Biosystems in their portfolios.
Ross also sold his 6,594-share stake in Nimble Storage Inc., a San Jose, Calif.-based flash storage solutions company, for an average price of $26.04 per share. The deal had a -0.02% impact on Ross’ portfolio.
Nimble Storage has a market cap of $2.03 billion and an enterprise value of $1.82 billion. It has a Price/Book of 12.0 and a Price/Sales of 7.0. Caxton Associates (Trades, Portfolio), Jim Simons (Trades, Portfolio) and PRIMECAP Management (Trades, Portfolio) have shares of Nimble Storage in their portfolios.
Nimble Storage’s second-quarter revenue was nearly 50% higher than a year ago and 12% higher than the company posted in the first quarter. Nimble Storage also recorded losses that were 15% higher than a year ago and slightly higher than the first quarter.
To view the portfolios of more gurus, visit the List of Gurus page. Not a premium member of GuruFocus? Try it free for 7 days.
